baber/WOPTO huggingface dataset:
Patent AT-E284205-T1 (AT)
Inventor: VENKATESWARA RAO PAVULURI MANA
IPC: A61K47/38
Filed: 2000-08-25
Granted: 2004-12-15
Abstract: The present invention relates to an improved pharmaceutical composition, in the form of a soft gel capsule resistant to digestive juice. The composition of the present invention is made up of gelatin and an enteric polymer in the form of free acid or its salt, containing a benzimidazole derivative used in the treatment of duodenal ulcers, solublised and/or suspended in a liquid or semisolid medium, comprising of a hydrophobic carrier, an alkaline inert to reacting material and a surface active agent and/or a solublising agent. The present invention also relates to a method for preparing the above said pharmaceutical composition.
Patent AT-E336670-T1 (AT)
Inventor: ZAWADZKI BERND
IPC: B60G21/055
Filed: 2001-01-19
Granted: 2006-09-15
Abstract: Stabilizer mounting (3) has 2-part bearing housing (2), provided by yoke part (1) with 2 yoke arms (5,6) and planar support wall (25) provided by part of automobile body structure, enclosing stabilizer rod, fitted with elastomer bush (14) having single longitudinal slit (15), with 2-part support element (18,19) fitted in space between planar support wall and elastomer bush. Longitudinal slit is aligned with yoke center plane in assembled position of stabilizer mounting.
Patent AT-E312553-T1 (AT)
Inventor: CHEN LONG-HSIUNG
IPC: A61B5/15
Filed: 2001-06-11
Granted: 2005-12-15
Abstract: A safety vacuum syringe for blood sampling conformed to ergonomics, mainly comprising: a hollow barrel (50), a directional sliding trench (52) being disposed transversely at one side of the front end of said barrel, and a sliding slit (54) being disposed transversely at another side opposite to said trench, a needle seat and a press plate (70) being further disposed in said trench and said slit respectively, wherein an eccentric reduced portion (62) is disposed on the upper surface of the needle seat, a guiding hole is disposed through the eccentric reduced portion to fix a  &boxdr&  Ð  &boxul& type needle therein and a lower needle tip (642) of the needle being placed at the central axial line of the reduced lining tube firmly, a needle head is further covered on said eccentric reduced portion, said press plate (70) has an end face and a guiding stick, said guiding stick has a triangle shape strip at its flank side, said sliding slit has triangle shape slit opening at its flank side corresponding to the position of the strip, so as to move the press plate as a guide; a vacuum tube, being disposed in said barrel, an elastic plug being covered on an opening at the upper side vacuum tube. <IMAGE>
Patent AT-E307821-T1 (AT)
Inventor: PEYMAN ANUSCHIRWAN DR
IPC: A61K31/70
Filed: 1993-01-21
Granted: 2005-11-15
Abstract: Oligonucleotide analogs (I) and their physiologically tolerable salts. Oligonucleotide analogs and their physiologically tolerable salts of formula (I) are new. R<1> = H, a substituent or -P(=W)ZZ'; R<2> = H, OH, 1-18C alkoxy, halo, azido or amino; B = nucleotide base residue; A = oxy or methylene; d, e, f = 0-50; i = 1-10; r = 0 or 1; W = oxo, selenoxo or thioxo; V = oxy, sulfandiyl or imino; Y = oxy, sulfandiyl, imino or methylene; Y' = oxy, sulfandiyl, imino, (CH2)m or V(CH2)m; m = 1-18; X = OH or SH; U, R<3>, R<4> = substituents; p = 1-100; q = 0-18; R<11> = H or functional group; Sp = a (3',5'-) spacer group of formula (i); g, g' = 0 or 1; h = 0-10; G = 1-12C alkylene (optionally substituted), (6-14C)aryldi-(1-8C)alkylene, 6-18C arylene, (CH2CH2V) alpha CH2CH2, (CH2V) alpha CH2, -(G-Y-P(=W)(U)-Y'-) beta  or a group of formula (ii);  alpha  = 1-11;  beta  = 1-6; Z, Z' = OH, (seleno)thio or a substituent; provided that r is 0 when V is Y' and is 1 if i is greater than 1. Positions of R<2> and the adjacent phosphoryl residue can be reversed; each nucleoside had D- or L-configuration and each B has alpha  or  beta  configuration. Independent claims are also included for: (1) a method for producing (I); (2) the phosphitylation reagent of formula DMTr-X'-G'-Y''-P(U')(NR<5>R<6>); and (3) a pharmaceutical composition containing at least one compound (I) and optionally auxiliary, carrier and/or other active agents. R<5>, R<6> = 1-12C alkyl or together form a 5-6 membered ring; DMTr = dimethoxytrityl; X', Y'' = oxy or sulfandiyl; U' = 1-4C alkyl or protected OH; G' = (CH2CH2O) alpha CH2CH2 or CH2CH(OR')CH2; and R' = 1-18C alkyl, 6-14C aryl or 6-14C aryl(1-8C) alkyl.
Patent AT-E324525-T1 (AT)
Inventor: EIMER GEORG DIPL-ING
IPC: A61M16/00
Filed: 2001-07-12
Granted: 2006-05-15
Abstract: The radial impeller (8) has a cover disc (10) on the axial end facing the outlet opening (6). Its diameter leaves only a narrow gap (30) for exit flow, between its outer edge and the internal circumference of the casing.
Patent AT-E408547-T1 (AT)
Inventor: DURHAM STEPHEN P
IPC: B62B1/12
Filed: 2001-07-16
Granted: 2008-10-15
Abstract: A dual wheel foldable hand truck with a nose plate (18) has a skeletal frame including laterally spaced vertical side rails. The frame has hingedly connected upper (17a) and lower (17b) frame sections with upper (19) and lower (26) side rails meeting at side rail interfaces. Handle operated lock slides (44) are carried by the upper rail sections for downward sliding movement to releasably lock the frame sections in planar alignment. The foldable nose (18) automatically locks in operative position when swung down from stowed position. <IMAGE>
Patent AT-E337262-T1 (AT)
Inventor: CLUESSERATH LUDWIG
IPC: B67C3/14
Filed: 2001-09-03
Granted: 2006-09-15
Abstract: The interior of each container (5) is filled with liquid by means of filler elements (1). The container in a filling phase is filled with hot liquid via a liquid-path (7,9) controlled by a valve (8) in the liquid-path, with filler elements heated to a filler element temperature. In the case of interruption to the filling process, the liquid-path is subjected to a hot flow medium in the form of a hot gas and or steam, in a section following the liquid-valve for maintaining the filler element temperature controlled by control elements or control valves (23,29).
Patent AT-E380278-T1 (AT)
Inventor: RENDER STEPHEN
IPC: E04C5/16
Filed: 2001-05-18
Granted: 2007-12-15
Abstract: This invention relates to a ladder spacer, and in particular to a ladder spacer for use with a reinforcing cage for a reinforced concrete structure. The reinforced concrete structure may be in the form of a column or pile or in the form of a diaphragm wall panel. According to the invention there is provided a ladder spacer (10) for a reinforcing cage (22), the ladder spacer comprising at least one bar (12; 28) adapted for securement to a part of a reinforcing cage (22), and at least one spacer means (14; 30; 50) secured to the bar, characterised in that the bar is formed non-linear. The bar(s) may be formed curved to engage the periphery of a pile cage, or may be of "L"-shape to engage the planar face and edge of a diaphragm wall panel. <IMAGE>
Patent AT-E366604-T1 (AT)
Inventor: KAIDONIS ARISTIDE
IPC: A62C3/02
Filed: 2001-01-09
Granted: 2007-08-15
Abstract: System includes main pipelines extending along length of tunnel, secondary pipelines, derived from main pipelines, electrovalves, manual valves, and water nozzles placed along secondary pipelines, at around 2 meters from ground. When alarm is triggered, nozzles produce water mist that traps smoke in upper half of tunnel, allowing people to move freely under water screen. System is triggered by manual fire alarms in tunnel, or by remote operator using thermocouple, smoke and IR sensors.
Patent AT-E255793-T1 (AT)
Inventor: OUZOUNIDIS JAN
IPC: H04L12/58
Filed: 2001-04-25
Granted: 2003-12-15
Abstract: A method and a corresponding system for enabling the sending of messages to a recipient via any of a number of messaging systems of different types are disclosed. In the method addresses for said recipient are stored. Furthermore, recipient availability information is received from the messaging systems. The recipient availability information is interpreted so as to determine in which of the messaging systems the recipient is currently available. Furthermore, an originator input including an identification of the recipient is received and an address among the stored addresses that are associated with messaging systems in which the recipient is currently available is chosen. Finally, the messaging system associated with the chosen address is identified. <IMAGE>
Patent AT-E412058-T1 (AT)
Inventor: YU DE-CHAO
IPC: C12N15/09
Filed: 2001-03-21
Granted: 2008-11-15
Abstract: Disclosed herein are replication-competent adenovirus vectors comprising co-transcribed first and second genes under transcriptional control of a heterologous, target cell-specific transcriptional regulatory element (TRE), wherein the second gene is under translational control of an internal ribosome entry site. Methods for the preparation and use of such vectors are also provided. The vectors provide target cell-specific virus replication in applications such as cancer therapy and gene therapy.
Patent AT-E381832-T1 (AT)
Inventor: AKKANEN JYRKI
IPC: H04M3/00
Filed: 2001-04-26
Granted: 2008-01-15
Abstract: This invention relates to routing in a communication network. The invention offers a method to make a protected routing through all the layers of a communication network. The bottom layer is the foundation for all protected routes. The routing order is from bottom to top. First, the first layer above the bottom layer is routed into the bottom layer. The links which do not need protection can be routed via the shortest path. The links which need protection are routed in a way that there exist two, as short as possible, separate paths. The other links are routed in a similar way. Finally the top layer is routed into the layer below the top layer.
Patent AT-E408413-T1 (AT)
Inventor: OCHIAI AKIKO
IPC: A61K9/12
Filed: 2001-05-29
Granted: 2008-10-15
Abstract: The preparation for intranasal administration comprising D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylal anyl-L-lysinamide (pralmorelin) and/or an acid addition salt thereof as an active ingredient and water permits a marked increase in the in vivo absorption of pralmorelin and hence provides adequate efficacy even if it is administered in a small dose at a time. The preparation also allows pralmorelin to be dissolved in an increased amount, so it can be formulated pharmaceutically with great ease. It also high stability over time.
Patent AT-E344670-T1 (AT)
Inventor: BISSERY MARIE-CHRISTINE
IPC: A61K45/00
Filed: 2001-02-26
Granted: 2006-11-15
Abstract: Therapeutic pharmaceutical compositions comprising a pyrimidine derivative in combination with camptothecin or a camptothecin derivative for the treatment of cancer are described. In one embodiment, the pyrimidine derivative is capecitabine and the camptothecin derivative is CPT-11.
Patent AT-E283084-T1 (AT)
Inventor: HAIKARAINEN JUSSI
IPC: A61M15/00
Filed: 2001-05-16
Granted: 2004-12-15
Abstract: A multiple-dose powder inhaler comprising an inhaler body defining a medicament container, an air channel, a mouthpiece, a rotatable metering drum with one or more peripheral dosing recesses and a dose counter for indicating the number of metered doses of medicament that have been dispensed from, or remain in, the medicament container. The inhaler is useful, for example, in the treatment of asthma.
Patent AT-E330958-T1 (AT)
Inventor: ORME MARK W
IPC: C07D453/02
Filed: 2001-05-15
Granted: 2006-07-15
Abstract: Compounds of the general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.
Patent AT-E414543-T1 (AT)
Inventor: WEBER MARTIN
IPC: A61K47/48
Filed: 2001-04-03
Granted: 2008-12-15
Abstract: The present invention relates to processes for the targeted transfection of cells, compositions which may be used for such processes, and corresponding pharmaceutical compositions for gene therapy. In particular, the invention relates to a process for introducing nucleic acid into cells comprising the steps of (a) mixing a nucleic acid with a dendrimer, in which a proportion of the dendrimer molecules are biotinylated; (b) mixing the resulting complex of nucleic acid and dendrimer with a second complex consisting of avidin or streptavidin and a biotinylated target-specific binding molecule; and (c) incubating the complex formed in step (b) with cells. Dendrimers which are well suited to the present invention include, for example, partially solvolysed polyamidoamine (PAMAM) dendrimers. Target-specific binding molecules are, in particular, cell-type-specific markers of the cell surface of the target cells.
Patent AT-E301479-T1 (AT)
Inventor: CHEN JOHN JIANHUA
IPC: A61L29/00
Filed: 2001-06-08
Granted: 2005-08-15
Abstract: The present invention relates to a catheter device having a dilatation balloon formed from a polymeric material crosslinked by moisture through —Si—O—Si— linkages, and to a method of making the same. The polymeric material is formed by reacting at least one organofunctional hydrolyzable silane with at least one polymer. The crosslinked polymeric structure is ideal for forming more resilient and durable catheter balloons. In particular, the catheter balloons have excellent abrasion resistance.
Patent AT-E326517-T1 (AT)
Inventor: JACQUES ALAIN
IPC: C11D1/52
Filed: 2001-05-24
Granted: 2006-06-15
Abstract: A stable, pourable and water dispersible fabric softening composition comprising:(i) from about 2% to about 35%, by weight, of a combination of softening components (A) and (B) wherein:(A) is a cationic fabric softening compound; and(B) is a fatty amide compound;(ii) from about 0 to about 10%, by weight, of a polysiloxane; and(iii) balance water and optionally adjuvants selected from the group consisting of perfumes; dyes; sequestrants; thickeners; and anti dye-transfer polymeric materials.
Patent AT-E346231-T1 (AT)
Inventor: BEST CHRISTOPHER HOWARD
IPC: F02M59/10
Filed: 2001-07-30
Granted: 2006-12-15
Abstract: A dual mode fuel injector having first ( 15 ) and second ( 30 ) valve members. The valve members are actuatable independently of one another and are arranged to open in opposite directions. The valve members control the flow through first ( 18 ) and second ( 29 ) orifices, one of which injects the fuel at a narrow angle with respect to the injector axis, and the other of which injects the fuel at a wider angle with respect to this axis.
Patent AT-E283061-T1 (AT)
Inventor: WINTER KAJ
IPC: A61K36/00
Filed: 2001-08-31
Granted: 2004-12-15
Abstract: Use of a composition comprising, as active ingredients, a water- and/or fat-soluble cytosolic extract of pollen and optionally pistils optionally combined with Royal Jelly and Vitamin E for manufacturing of a medicament for the treatment of disorders in relation to normal hormone variations in women of peri- and post-menopausal age.
Patent AT-E412270-T1 (AT)
Inventor: WILHELMSSON LEIF
IPC: G11B20/18
Filed: 2001-06-08
Granted: 2008-11-15
Abstract: An encoded signal that comprises a plurality of received encoded signal values is received by using an error correction decoding technique to generate a plurality of decoded signals from the encoded signal, wherein the plurality of decoded signals includes one or more decoded information signals and one or more decoded error detection signals. A correction value is generated that is representative of how much correction was performed by the error correction decoding technique to generate the plurality of decoded signals. The one or more decoded error detection signals are used to generate an error detection result. The decoded information signals are then alternatively accepted or rejected as a function of the error detection result and a comparison of the correction value with a threshold value.
Patent AT-E448306-T1 (AT)
Inventor: SPRINGER TIMOTHY
IPC: A01K67/027
Filed: 2001-08-31
Granted: 2009-11-15
Abstract: The present invention provides a method for stabilizing a protein in a desired conformation by introducing at least one disulfide bond into the polypeptide. Computational design is used to identify positions where crysteine residues can be introduced to form a disulfide bond in only one protein conformation, and therefore lock the protein in a given conformation. Accordingly, antibody and small molecule therapeutics are selected that are specific for the desired protein conformation. The invention also provides modified integrin I-domain polypeptides that are stabilized in a desired conformation. The invention further provides screening assays and therapeutic methods utilizing the modified integrin I-domains of the invention.
Patent AT-E385297-T1 (AT)
Inventor: BAUMGARTNER JOHANN
IPC: F16D65/54
Filed: 2001-08-14
Granted: 2008-02-15
Abstract: The brake has a caliper (1) overlapping the brake disc (3) and an actuating device for the brake linings (5,7). The actuating device has a turning lever (19) pref. operated by a piston rod. The lever has an aperture at one end to accommodate one end of the piston rod, and two further apertures in the outsides of the other end. Cap-shaped bearing shells and/or spherical bearing elements for the lever are fitted into the apertures, to hold the lever on the caliper and on at least one pressure piece to move the brake lining towards the brake disc.
Patent AT-E399603-T1 (AT)
Inventor: WAGSTAFFE CHRISTOPHER
IPC: B02C21/02
Filed: 2001-09-26
Granted: 2008-07-15
Abstract: A bulk material processing apparatus (10) which comprises: a longitudinally extending main frame (11); a supply conveyor (23) mounted on, and extending lengthwise of the main frame (11), and operative to convey a supply of bulk material from a forward lower end of the conveyor to an upper and rearward discharge end (24); a material processing device (13) mounted on the main frame (11) and arranged to receive material from the discharge end (24) of the supply conveyor (23), to process the material, and to discharge processed material; a discharge conveyor (32) mounted on the main frame (11) below the processing device (16) so as to be able to receive processed material discharged by the processing device, and to discharge the material to a discharge point located rearwardly of the apparatus; means (16, 17, 18) mounting the processing device (13) on the main frame (11) for movement between a raised operating position to a lowered transport position; and, means (34) mounting the discharge conveyor (32) on the main frame (11) for movement between a raised operative position and a lowered inoperative position; in which the discharge conveyor (32) has a first part (32a) which is mounted on the main frame, and a second part (32b) which is adjustable between an operative position in which it forms a prolongation of the first part, and a folded transport position in which it extends below the first part.
Patent AT-E408144-T1 (AT)
Inventor: AHMAD SULTAN
IPC: C12Q1/02
Filed: 2001-10-16
Granted: 2008-09-15
Abstract: The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays are based upon the binding of BAM-22P to the rat and human DRR receptors.
Patent AT-E343556-T1 (AT)
Inventor: JACOBSEN BENT
IPC: C03B37/05
Filed: 2001-08-02
Granted: 2006-11-15
Abstract: An MMVF batt is formed by cross lapping an MMVF web to a width of at least 3 metres and curing the batt by passing through a curing oven which is at least 3 metres wide. Rolls or other pieces having a length of at least 3 metres are formed by cutting the batt transversely.
Patent AT-E552572-T1 (AT)
Inventor: SWAHNEY HARPREET
IPC: G06K9/32
Filed: 2001-11-30
Granted: 2012-04-15
Abstract: Systems and techniques for synthesizing high-resolution images are described. Using as input hybrid high- and low-resolution images ( 110, 120 ), processing techniques including three-dimensional image warp-based ( 160 ) rendering may assist in developing the high-resolution output images. Enhanced results may in some instances be obtained by creating a high-resolution images of one member of a pair of stereo images by utilizing multiple frames of the other member of the pair.
Patent AT-E349245-T1 (AT)
Inventor: GRIT MUSTAFA DR
IPC: A61K8/00
Filed: 2002-01-17
Granted: 2007-01-15
Abstract: Gel composition for dyeing and tinting human hair has a Brookfield viscosity of 1000-50,000 mPa.s (spindle no.5, 25 degrees C) and comprises (wt.%): <??>(1) direct dye (0.001-5); <??>(2) long-chain quaternary ammonium compound (0.1-10); <??>(3) cationic polymer (0.1-5); <??>(4) nonionic and/or amphoteric or zwitterionic polymers (0.1-5); <??>(5) alcohol (ethanol, n-propanol and/or isopropanol) (15-50); and <??>(6) water.
Patent AT-E293352-T1 (AT)
Inventor: STEPPAT MANFRED
IPC: A01D43/08
Filed: 2002-02-15
Granted: 2005-05-15
Abstract: The maize harvester has cover plates which fit over the rotors (16). These have narrow front sections (30) which run along the base of the rotor teeth and sloping central sections (29) which channel the crop into the machine.
Patent AT-E296249-T1 (AT)
Inventor: WARNECKE KARL
IPC: B65G15/60
Filed: 2002-02-28
Granted: 2005-06-15
Abstract: The device for feeding articles through an angle comprises a conveyor belt (4) with a straight (8) and an angled (9) end. A guide (21, 22) is fitted to the angled end and diverts articles on to a second belt (3) with a straight end.
Patent AT-E347032-T1 (AT)
Inventor: CROMM GERD W
IPC: F04B25/00
Filed: 2002-03-23
Granted: 2006-12-15
Abstract: The compressor unit (10) has at least two compressor stages (11, 12) and an intermediate cooler (21) for compressed air connected to the first stage, and an after cooler (22) for compressed air connected to the last stage. The intermediate cooler and the after cooler are charged with cooling air by fans (38, 39).
Patent AT-E425541-T1 (AT)
Inventor: WORTMANN BIRGIT
IPC: G21F5/10
Filed: 2002-07-12
Granted: 2009-03-15
Abstract: A process for storing containers (1) that contain heat generating material, e.g. radioactive material, involves spacing the containers apart using a separating wall (2). Some of the heat generated by the containers is absorbed by the separating wall, and then emitted to the surroundings by convection.
Patent AT-E312150-T1 (AT)
Inventor: WANG FU-SHING
IPC: G02F1/15
Filed: 2002-08-22
Granted: 2005-12-15
Abstract: An electrochromic solution includes a hydrazone compound as an anodic compound is disclosed. The hydrazone compound has a general formula (I) <CHEM> where R1, R2, R3 and R4 are individually selected from a group consisting of hydrogen, alkyl containing 5 to 20 carbon atoms, alkenyl containing 2 to 20 carbon atoms, alkynyl containing 2 to 20 carbon atoms, and aryl containing 5 to 20 carbon atoms which are unsubstituted or optionally substituted with one or more ester, ether, aryl, amine, thioester, alkyl, alkoxy, alkene, alkyne, CN, F, Cl, Br, I and/or organometallocene functional group.
Patent AT-E445076-T1 (AT)
Inventor: BECKHAUSEN KARLHEINZ
IPC: E05F15/44
Filed: 2002-08-26
Granted: 2009-10-15
Abstract: A hollow elastomer section has a fastening section (2) and two chamber sections connected to it. One of the chamber sections contains switching elements that trigger a switching pulse fed to an evaluating unit if touched on both sides. The chamber section adjacent to the fastening section forms a switching chamber (3) linked to an outer chamber section forming an after-running chamber (4).